Search

Search Results

##search.searchResults.foundPlural##

SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP

Alessandro Laganà, Giovanni Manfredi Assanto, Chiara Masucci, Mauro Passucci, Livia Donzelli, Alessandra Serrao, Erminia Baldacci, Cristina Santoro, Antonio Chistolini

e2024020

2024-02-29

https://doi.org/10.4084/MJHID.2024.020

1041

PDF: 1228

HTML: 95
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

Michele Bibas, Gianluigi Biava, Andrea Antinori

e2011030

2011-07-08

https://doi.org/10.4084/mjhid.2011.030

3844

PDF: 1467

HTML: 8502
EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION

Mehrez Mehrez M. Jadaon

e2011037

2011-09-08

https://doi.org/10.4084/mjhid.2011.037

3094

PDF: 799

HTML: 12894
EPIDEMIOLOGY OF PROTHROMBIN G20210A MUTATION IN THE MEDITERRANEAN REGION

Mehrez M. Jadaon

e2011054

2011-11-28

https://doi.org/10.4084/mjhid.2011.054

2678

PDF: 1119

HTML: 2789
Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

Alessandro Laganà, Giovanni Manfredi Assanto, Mauro Passucci, Cristina Santoro, Antonio Chistolini

e2024047

2024-04-30

https://doi.org/10.4084/MJHID.2024.047

1152

PDF: 978

HTML: 88
ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST

Samir Arnaout, Hanady R. Samaha, Julien Succar, Imad Bou-Akl, Khaled M. Musallam, Ali T. Taher

e2011023

2011-05-23

https://doi.org/10.4084/mjhid.2011.023

1969

PDF: 858

HTML: 1338
Direct oral anticoagulants (DOACs) in the onco-hematologic patients

Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini

e2025022

2025-02-27

https://doi.org/10.4084/MJHID.2025.022

989

PDF: 969

HTML: 94
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease

Vincenzo De Sanctis

e2020032

2020-04-27

https://doi.org/10.4084/mjhid.2020.032

2127

PDF: 1408

HTML: 696
DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA

alessandra serrao, benedetta lucani, davide mansour, antonietta ferretti, erminia baldacci, cristina santoro, robin foà, antonio chistolini

e2019044

2019-06-25

https://doi.org/10.4084/mjhid.2019.044

1931

PDF: 1497

HTML: 438
Is laboratory monitoring useful in DOACs management?

Mario Biglietto, Rosaria Mormile, Matteo Totaro, Maria Laura Bisegna, Cristina Santoro, Antonio Chistolini

e2025019

2025-02-27

https://doi.org/10.4084/MJHID.2025.019

824

PDF: 794

HTML: 105
INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.

M. Al Huneini, Anil Pathare

e2017028

2017-04-20

https://doi.org/10.4084/mjhid.2017.028

2023

PDF: 906

HTML: 1357
BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini

e2025076

2025-10-31

https://doi.org/10.4084/MJHID.2025.076

376

PDF: 180

Html: 40
REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIE?TS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS

Vincenzo De Sanctis

e2017001

2017-01-01

https://doi.org/10.4084/mjhid.2017.001

6042

PDF: 1422

HTML: 1927
Protein S deficiency with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy

Kun Yang

e2024017

2024-02-29

https://doi.org/10.4084/MJHID.2024.017

571

PDF: 1051

HTML: 72
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

Francesco Rodeghiero

e2021032

2021-04-29

https://doi.org/10.4084/MJHID.2021.032

2445

PDF: 917

HTML: 513
REAL WORLD DATA ON CHARACTERISTICS AND MANAGEMENT OF COMMUNITY PATIENTS RECEIVING ANTICOAGULATION THERAPY WHO PRESENTED WITH ACUTE BLEEDING TO THE EMERGENCY DEPARTMENT AT A REGIONAL AUSTRALIAN HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. Anticoagulation and bleeding ?

Fayez Hanna, Annemarie Hyppa, Ajay Prakash, Usira Vithanarachchi, Hizb U Dawar, Zar Sanga, George Olabode, Hamish Crisp, Professor Alhossain A. Khalafallah

e2021017

2021-02-26

https://doi.org/10.4084/mjhid.2021.017

1556

PDF: 534

HTML: 306
IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?

Fahad Al-Eidan

e2015029

2015-04-19

https://doi.org/10.4084/mjhid.2015.029

1639

PDF: 816

HTML: 1463
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

Firas Kreidieh, Sally Temraz

e2020078

2020-10-27

https://doi.org/10.4084/mjhid.2020.078

1032

PDF: 959

HTML: 319
IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

Silvia Maria Trisolini, Alessandro Laganà, Saveria Capria

e2024060

2024-06-29

https://doi.org/10.4084/MJHID.2024.060

2039

PDF: 1785

HTML: 149
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

Zohreh Rahimi, Abbas Parsian

e2011024

2011-05-23

https://doi.org/10.4084/mjhid.2011.024

2221

PDF: 861

HTML: 2083
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

Nicola Semeraro, Prof. Mario Colucci

e2021045

2021-06-28

https://doi.org/10.4084/MJHID.2021.045

1946

PDF: 808

HTML: 216
CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri

e2024038

2024-04-30

https://doi.org/10.4084/MJHID.2024.038

2559

PDF: 1167

HTML: 101
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

Federico Mercolini, Simone Cesaro

e2022009

2022-01-01

https://doi.org/10.4084/MJHID.2022.009

2216

PDF: 930

HTML: 291
HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

Armando Tripodi

e2024027

2024-02-29

https://doi.org/10.4084/MJHID.2024.027

986

PDF: 1339

HTML: 124
BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

Giuseppe Leone, Eligio Pizzigallo

e2015057

2015-10-12

https://doi.org/10.4084/mjhid.2015.057

4816

PDF: 1958

HTML: 8303

1 - 25 of 25 items

Search

Search Results

SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP

HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

EPIDEMIOLOGY OF ACTIVATED PROTEIN C RESISTANCE AND FACTOR V LEIDEN MUTATION IN THE MEDITERRANEAN REGION

EPIDEMIOLOGY OF PROTHROMBIN G20210A MUTATION IN THE MEDITERRANEAN REGION

Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST

Direct oral anticoagulants (DOACs) in the onco-hematologic patients

CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease

DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA

Is laboratory monitoring useful in DOACs management?

INCREASED VASOOCCLUSIVE CRISIS IN “O” BLOOD GROUP SICKLE CELL DISEASE PATIENTS: ASSOCIATION WITH UNDERLYING THROMBOSPONDIN LEVELS.

BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIE?TS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS

Protein S deficiency with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy

PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

REAL WORLD DATA ON CHARACTERISTICS AND MANAGEMENT OF COMMUNITY PATIENTS RECEIVING ANTICOAGULATION THERAPY WHO PRESENTED WITH ACUTE BLEEDING TO THE EMERGENCY DEPARTMENT AT A REGIONAL AUSTRALIAN HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. Anticoagulation and bleeding ?

IS THE INCIDENCE TREND OF HEPARIN-INDUCED THROMBOCYTOPENIA DECREASED BY THE INCREASED USE OF LOW-MOLECULAR-WEIGHT-HEPARIN?

SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: PATHOPHYSIOLOGY, DIAGNOSIS AND OPEN ISSUES

SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

HOW THE HEMOSTASIS LABORATORY CAN HELP CLINICIANS TO MANAGE PATIENTS ON ORAL ANTICOAGULANTS

BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

Links

Information

Indexing

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

AskBisht

Facebook

MJHID in EuroPub Database

CLL UpDate

Keywords